Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis

Vascular endothelial growth factors (VEGF), Vascular endothelial growth factor receptors (VEGFR) and their downstream signaling pathways are promising targets in anti-angiogenic therapy. They constitute a crucial system to regulate physiological and pathological angiogenesis. In the last 20 years, m...

Full description

Bibliographic Details
Main Authors: Lei Wang, Wang-Qing Liu, Sylvain Broussy, Bingnan Han, Hongming Fang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
VEGF
VEGFR
angiogenesis
anti-angiogenic
inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1307860/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1307860/full

Similar Items